[Metabolic disorders in patients with chronic obstructive pulmonary disease]
Terapevticheskii Arkhiv
|May 29, 2007
Summary
Patients with chronic obstructive pulmonary disease (COPD) exhibit oxidative stress due to a weakened antioxidant defense system. This study highlights local-level oxidative damage in COPD patients.
Area of Science:
- Biochemistry
- Pulmonology
- Oxidative Stress Research
Context:
- Chronic obstructive pulmonary disease (COPD) is a major global health concern.
- Cellular dysregulation plays a significant role in COPD pathogenesis.
- Understanding local and systemic oxidative stress is crucial for COPD management.
Purpose:
- To investigate cell dysregulation in chronic obstructive pulmonary disease (COPD).
- To characterize oxidative stress markers at local and systemic levels in COPD patients.
- To assess the enzymatic anti-oxidant defense system in COPD.
Summary:
- This study examined 48 COPD patients, measuring glutathione levels and the activity of antioxidant enzymes like glutathione peroxidase, glutathione reductase, and catalase.
- Lipid peroxidation products, including diene conjugates, ketodienes, and coupled trienes, were analyzed in exhaled breath condensate.
- Results indicated significant oxidative stress at the local level in COPD patients, marked by a deficiency in the enzymatic anti-peroxide defense and increased lipid peroxidation intermediates.
Impact:
- Reveals a deficiency in the enzymatic anti-oxidant defense system in COPD patients.
- Demonstrates local-level oxidative stress in the respiratory system of individuals with COPD.
- Provides insights into the biochemical mechanisms underlying COPD progression.
Related Concept Videos
01:24Chronic Obstructive Pulmonary Disease
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
01:19Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations
Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet cell...
01:23Chronic Obstructive Pulmonary Disease I: Introduction
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
01:29Chronic Obstructive Pulmonary Disease-V: Management
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.